Clinical Trial Update: Safety, Tolerability and Pharmacokinetics of Inhaled Laninamivir Octanoate TwinCaps® DPI in Adults With Chronic Asthma [Phase 1]

View source ↗

Summary

Phase 1 trial update assessing safety, tolerability, and pharmacokinetics of inhaled laninamivir octanoate delivered as TwinCaps DPI in adults with chronic asth…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• TwinCaps Laninamivir Octanoate (Laninamivir octanoate)

Snippet

Sponsor: Biota Scientific Management Pty Ltd | Conditions: Asthma | Phase 1 | Status: COMPLETED